Cost-effectiveness analysis of selumetinib in the treatment of symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in Chinese children aged 3–18 years
ZHOU Wanxin, YANG Mengyu, CHANG Feng, LU Yun, ZHU Yumei
Chinese Journal of Hospital Pharmacy . 2025, (2): 181 -187 .  DOI: 10.13286/j.1001-5213.2025.02.10